Bioxytran, Inc SEC filings BIXT

Bioxytran, Inc has 470 filings in SEC EDGAR's recent list, going back to Oct 31, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.

Bioxytran, Inc SEC filings
Form Description Filed Period
DEF 14C Information statement Oct 15, 2018 Oct 15, 2018
PRE 14C Preliminary information statement Oct 3, 2018 Oct 3, 2018
DEF 14C Information statement Aug 13, 2018 Aug 1, 2018
PRE 14C Preliminary information statement Aug 1, 2018 Aug 1, 2018
DEF 14C Information statement Mar 31, 2015 Mar 19, 2015
PRE 14C Information statement Mar 19, 2015 Mar 19, 2015
DEF 14C Information statement Mar 3, 2015 Mar 2, 2015
DEF 14C Information statement Mar 3, 2015 Mar 2, 2015
PRE 14C Information statement Feb 19, 2015 Feb 18, 2015
PRE 14C Preliminary information statement Feb 18, 2015 Feb 18, 2015
PRE 14C Filing Feb 10, 2010 Feb 9, 2010
DEF 14A Proxy statement Oct 13, 2009 Oct 23, 2009
PRE 14A Preliminary proxy statement Sep 30, 2009 Oct 23, 2009

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BIXT (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Needham, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1445815
Former names
U.S. RARE EARTH MINERALS, INC. (until Oct 30, 2018); U.S. RARE EARTH MINERALS, INC (until Oct 3, 2018); U.S. Natural Nutrients & Minerals, Inc. (until Apr 14, 2011); AMERICA'S DRIVING RANGES, INC. (until Oct 29, 2009)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.